Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 236 clinical trials
A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.

To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient

  • 32 views
  • 07 Nov, 2020
  • 1 location
Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage

, randomized and double dummy controlled trial is to determine which of the two oral medications, CHM or micronized progesterone, and will mostly likely result in live birth in women with threatened

early pregnancy
  • 39 views
  • 25 Jan, 2021
  • 10 locations
  • 1 views
  • 08 Nov, 2020
Preparing and Timing of the Endometrium in Modified Natural Cycle Frozen-thawed Embryo Transfers

The increasing use of FET emphasizes the importance of preparing and timing the endometrium in FET cycles, however there is no consensus on luteal phase progesterone supplementation in mNC-FET

intracytoplasmic sperm injection
embryo transfer
progesterone
  • 7 views
  • 11 Apr, 2021
  • 1 location
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

This randomized clinical trial studies how well online genetics educational video with or without pre- and/or post-telephone genetics counseling works in assessing cancer-risk distress in patients with triple negative breast cancer. Online genetic education and telephone genetic counseling may help the doctors learn the stress a person feels about their …

genetic counseling
progesterone
genetic testing
cancer
triple negative breast cancer
  • 24 views
  • 23 Jan, 2021
  • 5 locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

treatment regimen
invasive breast cancer
adjuvant chemotherapy
sentinel lymph node biopsy
oophorectomy
  • 508 views
  • 24 Jan, 2021
  • 703 locations
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

MRI
epidermal growth factor receptor
sentinel node
triple-negative breast cancer
ductal carcinoma in situ
  • 814 views
  • 24 Jan, 2021
  • 811 locations
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual …

  • 139 views
  • 19 May, 2021
  • 482 locations
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

This clinical trial assesses whether a newly designed algorithm which looks at the genomic signature of each patient's tumor to predict their sensitivity to standard of care treatment verses being placed on a personally designed treatment trial can improve the responses in patients with newly diagnosed triple-negative breast cancer (TNBC). …

invasive breast cancer
HER2
absolute neutrophil count
triple-negative breast cancer
anthracyclines
  • 3 views
  • 31 May, 2021
  • 11 locations
Pre Operative Trastuzumab in Operable Breast Cancer

not be included. All node positive patients will receive single injection of Depot Inj. Progesterone 500 mg deep IM 4 -14 days prior to surgery Patients will be stratified, before

epidermal growth factor
adjuvant chemotherapy
her1
progesterone
tumor cells
  • 71 views
  • 26 Jan, 2021
  • 1 location